 | Up a level |
Segna, D; Bauer, D C; Feller, M; Schneider, C; Fink, H A; Aubert, C E; Collet, T-H; Da Costa, B R; Fischer, K; Peeters, R P; Cappola, A R; Blum, M; van Dorland, H A; Robbins, J; Naylor, K; Eastell, R; Uitterlinden, A G; Rivadeneira Ramirez, F; Gogakos, A; Gussekloo, J; ... (2018). Association between subclinical thyroid dysfunction and change in bone mineral density in prospective cohorts. Journal of internal medicine, 283(1), pp. 56-72. Blackwell Scientific Publications 10.1111/joim.12688
Eastell, R; Lang, T; Boonen, S; Cummings, S; Delmas, PD; Cauley, JA; Horowitz, Z; Kerzberg, E; Bianchi, G; Kendler, D; Leung, P; Man, Z; Mesenbrink, P; Eriksen, EF; Black, DM; HORIZON, Pivotal Fracture Trial. (2010). Effect of once-yearly zoledronic acid on the spine and hip as measured by quantitative computed tomography: results of the HORIZON Pivotal Fracture Trial. Osteoporosis international, 21(7), pp. 1277-85. London: Springer 10.1007/s00198-009-1077-9
Cummings, SR; San, Martin J; McClung, MR; Siris, ES; Eastell, R; Reid, IR; Delmas, P; Zoog, HB; Austin, M; Wang, A; Kutilek, S; Adami, S; Zanchetta, J; Libanati, C; Siddhanti, S; Christiansen, C; FREEDOM, Trial (2009). Denosumab for prevention of fractures in postmenopausal women with osteoporosis. New England journal of medicine NEJM, 361(8), pp. 756-765. Waltham, Mass.: Massachusetts Medical Society MMS 10.1056/NEJMoa0809493
